Pharma Scientist

Pharma Scientist is designed to provide the latest news in Advanced Therapies, Controlled Substances, Digital & Social Media, Drug Discovery & Development, Pharma & BioPharma + more!

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

RESEARCH

UCONN STARTUP DIANT BAGS LICENSE FOR CONTINUOUS NANOPARTICLE MANUFACTURING TECH

UConn | November 20, 2020

news image

Consistent assembling has just begun to override customary group handling in the domain of tablet creation. The following region due for an assembling update? Nanoparticle drug conveyance frameworks, one startup thinks—and it's currently prepared to pitch its foundation to drugmakers. The University of Connecticut as of late authorized its ceaseless nanoparticle fabricating innovation to DIANT Pharma, a startup helped to establish by the stage's designers Antonio Cos...

Read More

PHARMA TECH

PIRAMAL PHARMA SOLUTIONS ANNOUNCES STERILE FILL/FINISH PROGRAM THERATECHNOLOGIES INC

Piramal Pharma Solutions, Theratechnologies Inc. | January 25, 2021

news image

Piramal Pharma Limited's Pharma Solutions business, a leading contract development and manufacturing organization (CDMO), today declared that it is giving Theratechnologies Inc. with GMP manufacturing of sterile fill/finish drug item to help their developmental item as it goes into a first-in-people clinical investigation. The clinical material is being created at the Piramal Pharma Solutions (PPS) manufacturing site in Lexington, Kentucky, which is perceived around the world ...

Read More

ZEALAND PHARMA STRENGTHENS EXECUTIVE TEAM WITH NEW U.S. LEADERSHIP

Globe newswire | June 15, 2020

news image

Zealand Pharma, a biotechnology company changing lives with innovative peptide-based medicines, today announced the appointment of Frank Sanders as President of Zealand Pharma U.S. Frank will join Zealand on July 6, 2020. “I am pleased to welcome Frank Sanders to Zealand Pharma, and am confident that he will provide strong and experienced leadership for our U.S. organization,” said Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma. “Frank has more than 25 ...

Read More

PHARMACY MARKET

SUNOVION AND OTSUKA INITIATE PHASE 3 CLINICAL DEVELOPMENT OF NON-RACEMIC AMISULPRIDE FOR THE TREATMENT OF PEOPLE WITH BIPOLAR DEPRESSION

Sunovion Pharmaceuticals Inc. | February 10, 2022

news image

Sunovion Pharmaceuticals Inc. and Otsuka Pharmaceutical Development And Commercialization, Inc. announced that the first patient has been randomized in SEP380-301, a Phase 3 clinical study evaluating non-racemic amisulpride for the treatment of major depressive episodes associated with bipolar I disorder (bipolar depression). Non-racemic amisulpride is being jointly developed and commercialized as part of a collaboration between Sunovion, its parent company Sumitomo Dainippon Pharma and Otsuka P...

Read More
news image

RESEARCH

UCONN STARTUP DIANT BAGS LICENSE FOR CONTINUOUS NANOPARTICLE MANUFACTURING TECH

UConn | November 20, 2020

Consistent assembling has just begun to override customary group handling in the domain of tablet creation. The following region due for an assembling update? Nanoparticle drug conveyance frameworks, one startup thinks—and it's currently prepared to pitch its foundation to drugmakers. The University of Connecticut as of late authorized its ceaseless nanoparticle fabricating innovation to DIANT Pharma, a startup helped to establish by the stage's designers Antonio Cos...

Read More
news image

PHARMA TECH

PIRAMAL PHARMA SOLUTIONS ANNOUNCES STERILE FILL/FINISH PROGRAM THERATECHNOLOGIES INC

Piramal Pharma Solutions, Theratechnologies Inc. | January 25, 2021

Piramal Pharma Limited's Pharma Solutions business, a leading contract development and manufacturing organization (CDMO), today declared that it is giving Theratechnologies Inc. with GMP manufacturing of sterile fill/finish drug item to help their developmental item as it goes into a first-in-people clinical investigation. The clinical material is being created at the Piramal Pharma Solutions (PPS) manufacturing site in Lexington, Kentucky, which is perceived around the world ...

Read More
news image

ZEALAND PHARMA STRENGTHENS EXECUTIVE TEAM WITH NEW U.S. LEADERSHIP

Globe newswire | June 15, 2020

Zealand Pharma, a biotechnology company changing lives with innovative peptide-based medicines, today announced the appointment of Frank Sanders as President of Zealand Pharma U.S. Frank will join Zealand on July 6, 2020. “I am pleased to welcome Frank Sanders to Zealand Pharma, and am confident that he will provide strong and experienced leadership for our U.S. organization,” said Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma. “Frank has more than 25 ...

Read More
news image

PHARMACY MARKET

SUNOVION AND OTSUKA INITIATE PHASE 3 CLINICAL DEVELOPMENT OF NON-RACEMIC AMISULPRIDE FOR THE TREATMENT OF PEOPLE WITH BIPOLAR DEPRESSION

Sunovion Pharmaceuticals Inc. | February 10, 2022

Sunovion Pharmaceuticals Inc. and Otsuka Pharmaceutical Development And Commercialization, Inc. announced that the first patient has been randomized in SEP380-301, a Phase 3 clinical study evaluating non-racemic amisulpride for the treatment of major depressive episodes associated with bipolar I disorder (bipolar depression). Non-racemic amisulpride is being jointly developed and commercialized as part of a collaboration between Sunovion, its parent company Sumitomo Dainippon Pharma and Otsuka P...

Read More